Trial intelligence / Profile preview

Avenova vs Betadine for Conjunctival Prep

NCT04981860Phase 4Suspended

Sponsor
University of Miami
Start
Aug 2021
Primary completion
Dec 2025
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Phase 4, randomised, open-label trial of hypochlorous acid in bacterial eye infection (4 arms), sponsored by University of Miami. Primary endpoint: Number of bacterial Colony Forming Units at Day 1. Started Aug 2021; status: suspended.

02

Drugs

hypochlorous acid
03

Conditions

bacterial eye infection

Beyond the preview

Go deeper on NCT04981860.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04981860.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call